Statin-Associated Necrotizing Autoimmune Myopathy Unmasked by Statin Re-exposure

Research has documented a case of statin-associated necrotizing autoimmune myopathy (NAM) unmasked by statin re-exposure in a 65-year-old man. The patient had experienced worsening, painless proximal muscle weakness and significant creatine kinase (CK) elevation shortly after resuming statin therapy following a temporary discontinuation. Diagnostic workup revealed positive 3-hydroxy-3-methylglutaryl-CoA reductase antibodies (HMGCR Ab), magnetic resonance imaging (MRI) findings consistent with inflammatory myopathy, and a muscle biopsy demonstrating scattered necrotic and regenerating fibers, characteristic of immune-mediated necrotizing myopathy (IMNM). This case highlights the potential for statin re-exposure to unmask or exacerbate evolving NAM in patients with subclinical disease.

Key Takeaways:

  • Necrotizing autoimmune myopathy (NAM) is an uncommon inflammatory muscle disease marked by progressive weakness and elevated muscle enzymes.
  • The disease may develop in association with statin use, particularly when specific autoantibodies are present.
  • Statin re-exposure can unmask or exacerbate evolving NAM in patients with subclinical disease.
  • Clinicians should maintain a high index of suspicion for NAM in statin-treated individuals presenting with unexplained muscle weakness or transaminitis.
  • Early recognition and timely initiation of therapy are critical to prevent irreversible muscle damage and improve clinical outcomes.
  • The patient's symptoms, including painless proximal muscle weakness and significant CK elevation, were initially misattributed to hepatic steatosis.
  • The diagnostic workup revealed positive HMGCR Ab, MRI findings consistent with inflammatory myopathy, and a muscle biopsy demonstrating scattered necrotic and regenerating fibers.

Statistics:

  • 3-hydroxy-3-methylglutaryl-CoA reductase antibodies (HMGCR Ab) were present in the patient.
  • Magnetic resonance imaging (MRI) findings were consistent with inflammatory myopathy.
  • Muscle biopsy demonstrated scattered necrotic and regenerating fibers, characteristic of immune-mediated necrotizing myopathy (IMNM).
  • The patient's creatine kinase (CK) levels were significantly elevated.

Sources:

  • Anthony Martins, Internal Medicine, Ocean University Medical Center, Brick, United States
  • Aurora Cafuli
  • Nosagie Ohonba
  • Donahue K. Johnson
  • Sofia Terner
  • NewsRx. Studies by Anthony Martins and Co-Authors Describe New Findings in Autoimmunity [Statin-Associated Necrotizing Autoimmune Myopathy: Unmasking 3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR) Antibody-Positive Disease After Statin Re-exposure]. Health & Medicine Week. September 19, 2025; p 6949.